LUCILLE MILLER: Open Payments
NPI 1104330026 · SICKLERVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,732 in 114 payments from 15 companies in 2025. Trend: 2023 $1,571 · 2024 $2,188 · 2025 $2,732
Food & beverage: $2,665Education: $67
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $885 |
| GlaxoSmithKline, LLC. | 26 | $454 |
| Regeneron Healthcare Solutions, Inc. | 19 | $363 |
| GENZYME CORPORATION | 12 | $337 |
| Baxter Healthcare | 7 | $165 |
| Amgen Inc. | 5 | $80 |
| Philips North America LLC | 4 | $79 |
| Grifols USA, LLC | 4 | $78 |
| Verona Pharma, Inc. | 4 | $68 |
| SANOFI-AVENTIS U.S. LLC | 1 | $67 |
Products named: DUPIXENT, BREZTRI, NUCALA, AIRSUPRA, FASENRA, TEZSPIRE, TRELEGY ELLIPTA, Vest Therapy Und.
Industry payments across NJ — which companies pay providers there.
